CN103750425B - 一种高丽红参罗汉果汤的制备方法 - Google Patents
一种高丽红参罗汉果汤的制备方法 Download PDFInfo
- Publication number
- CN103750425B CN103750425B CN201410004204.2A CN201410004204A CN103750425B CN 103750425 B CN103750425 B CN 103750425B CN 201410004204 A CN201410004204 A CN 201410004204A CN 103750425 B CN103750425 B CN 103750425B
- Authority
- CN
- China
- Prior art keywords
- red ginseng
- hawthorn
- korean red
- residue
- year
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000002789 Panax ginseng Nutrition 0.000 title claims abstract description 57
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 235000014347 soups Nutrition 0.000 title claims abstract description 10
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 32
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 30
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 30
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 30
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 30
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 30
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 30
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 30
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 30
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 30
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 30
- 239000000843 powder Substances 0.000 claims abstract description 30
- 240000000249 Morus alba Species 0.000 claims abstract description 25
- 239000000706 filtrate Substances 0.000 claims abstract description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 14
- 241000186000 Bifidobacterium Species 0.000 claims abstract description 13
- 235000013399 edible fruits Nutrition 0.000 claims description 35
- 241001092040 Crataegus Species 0.000 claims description 29
- 244000185386 Thladiantha grosvenorii Species 0.000 claims description 23
- 235000011171 Thladiantha grosvenorii Nutrition 0.000 claims description 22
- 238000009835 boiling Methods 0.000 claims description 13
- YIKYNHJUKRTCJL-UHFFFAOYSA-N Ethyl maltol Chemical compound CCC=1OC=CC(=O)C=1O YIKYNHJUKRTCJL-UHFFFAOYSA-N 0.000 claims description 8
- 229940093503 ethyl maltol Drugs 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 7
- 229910000831 Steel Inorganic materials 0.000 claims description 4
- 238000000855 fermentation Methods 0.000 claims description 4
- 230000004151 fermentation Effects 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 4
- 239000010959 steel Substances 0.000 claims description 4
- 244000126002 Ziziphus vulgaris Species 0.000 abstract description 5
- 239000000047 product Substances 0.000 abstract description 3
- 238000005728 strengthening Methods 0.000 abstract description 3
- 235000006545 Ziziphus mauritiana Nutrition 0.000 abstract description 2
- 235000008529 Ziziphus vulgaris Nutrition 0.000 abstract description 2
- 235000013402 health food Nutrition 0.000 abstract description 2
- 238000012827 research and development Methods 0.000 abstract description 2
- 240000000171 Crataegus monogyna Species 0.000 abstract 1
- 229910001220 stainless steel Inorganic materials 0.000 abstract 1
- 239000010935 stainless steel Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 21
- 230000001093 anti-cancer Effects 0.000 description 9
- 241000218231 Moraceae Species 0.000 description 8
- 240000004371 Panax ginseng Species 0.000 description 8
- 235000008434 ginseng Nutrition 0.000 description 8
- 239000008280 blood Substances 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- NOEGNKMFWQHSLB-UHFFFAOYSA-N 5-hydroxymethylfurfural Chemical compound OCC1=CC=C(C=O)O1 NOEGNKMFWQHSLB-UHFFFAOYSA-N 0.000 description 5
- 206010028980 Neoplasm Diseases 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 229930003231 vitamin Natural products 0.000 description 5
- 239000011782 vitamin Substances 0.000 description 5
- 235000013343 vitamin Nutrition 0.000 description 5
- 229940088594 vitamin Drugs 0.000 description 5
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 201000011510 cancer Diseases 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 239000000470 constituent Substances 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 150000003722 vitamin derivatives Chemical class 0.000 description 4
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 3
- WRYLYDPHFGVWKC-UHFFFAOYSA-N 4-terpineol Chemical compound CC(C)C1(O)CCC(C)=CC1 WRYLYDPHFGVWKC-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 3
- 235000003140 Panax quinquefolius Nutrition 0.000 description 3
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000003712 anti-aging effect Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 201000006549 dyspepsia Diseases 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 239000001630 malic acid Substances 0.000 description 3
- 235000011090 malic acid Nutrition 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 3
- 229930182490 saponin Natural products 0.000 description 3
- 150000007949 saponins Chemical class 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 229930192392 Mitomycin Natural products 0.000 description 2
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 2
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 230000007969 cellular immunity Effects 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 230000001077 hypotensive effect Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 229960004857 mitomycin Drugs 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000001568 sexual effect Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- DBOVHQOUSDWAPQ-UHFFFAOYSA-N (4aS)-6c-[O2-(3,5,3'-trihydroxy-biphenyl-2-carbonyl)-beta-D-glucopyranosyloxy]-5t-vinyl-(4ar)-4,4a,5,6-tetrahydro-3H-pyrano[3,4-c]pyran-1-one Natural products OC1C(O)C(CO)OC(OC2C(C3C(C(OCC3)=O)=CO2)C=C)C1OC(=O)C1=C(O)C=C(O)C=C1C1=CC=CC(O)=C1 DBOVHQOUSDWAPQ-UHFFFAOYSA-N 0.000 description 1
- STGNLGBPLOVYMA-MAZDBSFSSA-N (E)-but-2-enedioic acid Chemical compound OC(=O)\C=C\C(O)=O.OC(=O)\C=C\C(O)=O STGNLGBPLOVYMA-MAZDBSFSSA-N 0.000 description 1
- XUCIJNAGGSZNQT-JHSLDZJXSA-N (R)-amygdalin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O[C@@H](C#N)C=2C=CC=CC=2)O1 XUCIJNAGGSZNQT-JHSLDZJXSA-N 0.000 description 1
- FZIPCQLKPTZZIM-UHFFFAOYSA-N 2-oxidanylpropane-1,2,3-tricarboxylic acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.OC(=O)CC(O)(C(O)=O)CC(O)=O FZIPCQLKPTZZIM-UHFFFAOYSA-N 0.000 description 1
- WRYLYDPHFGVWKC-SNVBAGLBSA-N 4-Terpineol Natural products CC(C)[C@]1(O)CCC(C)=CC1 WRYLYDPHFGVWKC-SNVBAGLBSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010049865 Achromotrichia acquired Diseases 0.000 description 1
- BZXINCMCFVKGKB-UHFFFAOYSA-N Amarogentin Natural products OCC1OC(OC2OC=C3C(CCOC3=O)C2C=C)C(OC(=O)c4cc(O)cc(O)c4c5cccc(O)c5)C(O)C1O BZXINCMCFVKGKB-UHFFFAOYSA-N 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 102000040350 B family Human genes 0.000 description 1
- 108091072128 B family Proteins 0.000 description 1
- 201000006474 Brain Ischemia Diseases 0.000 description 1
- 102100034279 Calcium-binding mitochondrial carrier protein Aralar2 Human genes 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241001070941 Castanea Species 0.000 description 1
- 235000014036 Castanea Nutrition 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 206010008120 Cerebral ischaemia Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 241000726221 Gemma Species 0.000 description 1
- 241000427324 Glinus Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 208000015710 Iron-Deficiency Anemia Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 244000018795 Prunus mume Species 0.000 description 1
- 235000011158 Prunus mume Nutrition 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 240000005049 Prunus salicina Species 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 1
- 241000220222 Rosaceae Species 0.000 description 1
- 241000282849 Ruminantia Species 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 241001409305 Siraitia Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000004308 accommodation Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- DBOVHQOUSDWAPQ-WTONXPSSSA-N amarogentin Chemical compound O([C@H]1[C@H](O[C@H]2[C@@H]([C@H]3C(C(OCC3)=O)=CO2)C=C)O[C@@H]([C@H]([C@@H]1O)O)CO)C(=O)C1=C(O)C=C(O)C=C1C1=CC=CC(O)=C1 DBOVHQOUSDWAPQ-WTONXPSSSA-N 0.000 description 1
- 229940089837 amygdalin Drugs 0.000 description 1
- YZLOSXFCSIDECK-UHFFFAOYSA-N amygdalin Natural products OCC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC(C#N)c3ccccc3 YZLOSXFCSIDECK-UHFFFAOYSA-N 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 229930014669 anthocyanidin Natural products 0.000 description 1
- 150000001452 anthocyanidin derivatives Chemical class 0.000 description 1
- 235000008758 anthocyanidins Nutrition 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003474 anti-emetic effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000003005 anti-senility effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000002111 antiemetic agent Substances 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- BHLWLVTYEDJFGZ-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1.O=CC1=CC=CC=C1 BHLWLVTYEDJFGZ-UHFFFAOYSA-N 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- OVYQSRKFHNKIBM-UHFFFAOYSA-N butanedioic acid Chemical compound OC(=O)CCC(O)=O.OC(=O)CCC(O)=O OVYQSRKFHNKIBM-UHFFFAOYSA-N 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- -1 carrotene Proteins 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 108010084210 citrin Proteins 0.000 description 1
- 235000020965 cold beverage Nutrition 0.000 description 1
- 239000012230 colorless oil Substances 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- MDZKJHQSJHYOHJ-UHFFFAOYSA-N crataegolic acid Natural products C1C(O)C(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MDZKJHQSJHYOHJ-UHFFFAOYSA-N 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 239000003866 digestant Substances 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 235000018927 edible plant Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000012259 ether extract Substances 0.000 description 1
- YGHHWSRCTPQFFC-UHFFFAOYSA-N eucalyptosin A Natural products OC1C(O)C(O)C(CO)OC1OC1C(OC(C#N)C=2C=CC=CC=2)OC(CO)C(O)C1O YGHHWSRCTPQFFC-UHFFFAOYSA-N 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000021022 fresh fruits Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 229930182494 ginsenoside Natural products 0.000 description 1
- 229940089161 ginsenoside Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000004153 glucose metabolism Effects 0.000 description 1
- 230000002414 glycolytic effect Effects 0.000 description 1
- KYYWBEYKBLQSFW-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCC(O)=O KYYWBEYKBLQSFW-UHFFFAOYSA-N 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000007688 immunotoxicity Effects 0.000 description 1
- 231100000386 immunotoxicity Toxicity 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 231100000225 lethality Toxicity 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000002366 lipolytic effect Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- MDZKJHQSJHYOHJ-LLICELPBSA-N maslinic acid Chemical compound C1[C@@H](O)[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MDZKJHQSJHYOHJ-LLICELPBSA-N 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 229930189775 mogroside Natural products 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- NIFHFRBCEUSGEE-UHFFFAOYSA-N oxalic acid Chemical compound OC(=O)C(O)=O.OC(=O)C(O)=O NIFHFRBCEUSGEE-UHFFFAOYSA-N 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 108010004621 phosphoketolase Proteins 0.000 description 1
- 235000021018 plums Nutrition 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 235000021283 resveratrol Nutrition 0.000 description 1
- 229940016667 resveratrol Drugs 0.000 description 1
- 230000005070 ripening Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 230000035946 sexual desire Effects 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 210000003556 vascular endothelial cell Anatomy 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L23/00—Soups; Sauces; Preparation or treatment thereof
- A23L23/10—Soup concentrates, e.g. powders or cakes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
Abstract
本发明所属保健食品研究开发技术领域。本发明涉及一种高丽红参罗汉果汤的制备方法。取高丽红参5年根粉末、罗汉果、桑椹、乌梅、山楂、大枣放入不锈钢容器内，加水煎煮3次，得滤液，加入双歧杆菌粉末发酵；将滤液减压浓缩至20-40mL，装瓶或装袋即可。本发明产品具有强身健体的功能。
Description
技术领域
本发明所属保健食品研究开发技术领域。本发明涉及一种高丽红参罗汉果汤的制备方法。本发明产品具有强身健体的功能。
背景技术
1高丽红参系由产自韩国的高丽园参经蒸、烘烤加工而成，在加工高丽红参过程中，有新的抗癌活性成分产生。高丽红参不凉也不热，属于温性；高丽参虽性温但补性强，益气助火。高丽参又分白参和红参，脾虚火旺者宜用白参，因“生用气凉，微苦补阴”;脾虚肺怯者宜用红参，“熟用气温，味甘补阳”。总体来说，高丽参更适合老年气虚症状明显的人服用，能强壮体质，增强免疫力。
高丽红参的功效：
（1）益智健脑：对记忆力减退和运动协调能力下降的人以及经常喝酒或接触带乙醇成分的食物、药物的人，高丽红参具有提高脑力工作能力、增强记忆力和改善脑缺血性障碍的功效
（2）镇痛：一些专家通过做传感神经细胞试验发现，高丽参对身体各种疼痛症状都有所帮助。
（3）防癌和抗癌：高丽红参的皂苷成分和非皂苷成分有抑制多种癌细胞的增殖活性，同时也可抑制癌细胞转移。另外，高丽红参与抗癌剂同服用，抗癌效果要好于单独用抗癌剂(丝裂霉素)。这是因为肿瘤化疗中癌细胞易形成耐受，高丽红参与抗癌剂同服用，增强对癌细胞的杀伤力、减轻抗癌剂的副作用。
（4）增强免疫力：高丽红参提取物可恢复因服用具有免疫毒性的抗癌剂(丝裂霉素)而下降的细胞性免疫反应，尤其乙醚提取物可激活或增强细胞性免疫，及自然杀伤细胞的活性，对提高免疫力有很大的功效。
（5）控制糖尿病：高丽红参含有促进胰岛素分泌和类似胰岛素作用的物质，其中人参皂苷能改善高血糖，有效地控制糖尿病的发生。
（6）健肝：高丽参成分中有抗肝炎活性，具有解毒、保护肝脏及促进肝再生、恢复的作用。此外，高丽红参还有解酒、消除宿醉的作用。
（7）调节血压：高丽红参具有扩张血管作用，能改善血液循环，其中的皂苷成分通过促进血管内皮细胞释放一氧化氮，可达到降血压作用。
（8）抗疲劳及抗压：经研究发现，持续服用高丽红参可以提高运动能力和缓解疲劳，对促进运动员疲劳累积的恢复和预防运动性贫血有很大帮助;此外，高丽红参还可以增强对低温(5℃、0℃、-10℃)及高温(35℃)等不利环境的耐受力，通过对压力或环境变化进行精妙调节，提高抗压能力，维持机体稳定性。
（9）改善女性更年期障碍：据调查，有更年期障碍症状的女性在服用高丽红参后，有80%的人承认服用高丽红参后症状明显改善。专家称，这些女性如根据症状来调整用量，还可提高疗效。
（10）改善男性性功能障碍：高丽红参可防止因压力导致的男性性功能障碍。经临床试验，勃起障碍患者(90人)服用高丽红参后，在勃起程度、性欲及满意度等方面都有所改善。
（11）抗氧化及抗衰老：高丽红参具有抑制有害活性氧的增多和脂类过氧化的抗氧化效果。
2罗汉果罗汉果（学名：Siraitia grosvenori）是我国特有的珍贵葫芦科植物，素有良药佳果之称，用途广泛，畅销国内外市场，在国际市场上享有很高的声誉。是中国广西著名特产。中医以其果实入药，含有罗汉果甜苷、丰富的葡萄糖、果糖、多种氨基酸和维生素等药用成分，清热润肺，止咳，利咽，滑肠通便。主治肺热痰火咳嗽、咽喉炎、扁桃体炎、急性胃炎、便秘等。用罗汉果少许，冲入开水浸泡，是一种极好的清凉饮料，既可提神生津，又可预防呼吸道感染，常年服用，能延年益寿，罗汉果汁还可用于烹调，清香可口，罗汉果被人们誉为“神仙果”。
3桑椹又名桑葚，为桑科落叶乔木桑树的成熟果实，桑葚又叫桑果、桑枣，农人喜欢其成熟的鲜果食用，味甜汁多，是人们常食的水果之一。因桑树特殊的生长环境使桑果具有天然生长，无任何污染的特点，所以桑葚又被称为“民间圣果”。现代研究证实，桑葚果实中含有丰富的活性蛋白、维生素、氨基酸、胡萝卜素、矿物质、白藜芦醇、花青素等成份，营养是苹果的5～6倍，是葡萄的4倍，具有多种功效，被医学界誉为“二十一世纪的最佳保健果品”。常吃桑葚能显著提高人体免疫力，具有延缓衰老，美容养颜的功效。桑葚既可入食，又可入药，中医认为桑葚味甘酸，性微寒，入心、肝、肾经，为滋补强壮、养心益智佳果。具有，主治阴血不足而致的头晕目眩，耳鸣心悸，烦躁失眠，腰膝酸软，须发早白，消渴口干，大便干结等症。
4山楂可食用植物，质硬，果肉薄，味微酸涩；落叶灌木，枝密生，有细刺，幼枝有柔毛；小枝紫褐色，老枝灰褐色。
山楂的营养价值：
山楂含多种维生素、山楂酸、酒石酸、柠檬酸、苹果酸等，还含有黄酮类、内酯、糖类、蛋白质、脂肪和钙、磷、铁等矿物质，所含的解脂酶能促进脂肪类食物的消化。促进胃液分泌和增加胃内酶素等功能。中医认为，山楂具有消积化滞、收敛止痢、活血化淤等功效。主治饮食积滞、胸膈脾满、疝气血淤闭经等症。山楂中含有山萜类及黄酮类等药物成分，具有显著的扩张血管及降压作用，有增强心肌、抗心律不齐、调节血脂及胆固醇含量的功能。适应范围：一般人皆可食用。儿童、老年人、消化不良尤其适合食用。伤风感冒、消化不良、食欲不振、儿童软骨缺钙症、儿童缺铁性贫血者可多食山楂片。
山楂的功效与作用：
（1）防治心血管疾病，降低血压和胆固醇、软化血管及利尿和镇静作用；
（2）开胃消食，特别对消肉食积滞作用更好，很多助消化的药中都采用了山楂；
（3）山楂有活血化淤的功效，有助于解除局部淤血状态，对跌打损伤有辅助疗效；
（4）山楂中有平喘化痰、抑制细菌、治疗腹痛腹泻的成分。
5乌梅别名酸梅、黄仔、合汉梅、干枝梅，为蔷薇科落叶乔木植物梅Prunus mume的近成熟果实。果实含枸橼酸(citric acid），苹果酸(malic acid），草酸(oxalic acid），琥珀酸(succinic acid）和延胡索酸(fumaric acid）总酸量约4%-5.5%，以前两种有机酸的含量较多。还含5-羟甲基-2-糠醛(5-hydroxymethyl-2-furaldehyde），为无色油状物。所含挥发性成分，主要有苯甲醛(benzaldehyde)62.40%，4-松油烯醇(terpinen-4-ol)3.97%，苯甲醇（benzyl alcohol)3.97%和十六烷酸(hexadecanoic acid)4.55%。乌梅仁含苦杏仁苷(amygdalin）约0.5%，而梅仁含约4.3%。另有报道乌梅中还含苦味酸（picric acid）和超氧化物歧化酶(SOD）。具有保护肠胃、消除便秘、增进食欲、改善肝脏机能、防老化、清血、可软化血管，推迟血管硬化、孕妇止吐、解酒功能、增加能量、能预防疾病、防老抗衰及消除疲劳的功能。乌梅提取物也可作为天然防腐剂。
6大枣又名红枣、干枣、枣子，起源于中国，在中国已有八千多年的种植历史，自古以来就被列为“五果”（栗、桃、李、杏、枣）之一。大枣富含蛋白质、脂肪、糖类、胡萝卜素、B族维生素、维生素C、维生素P以及钙、磷、铁和环磷酸腺苷等营养成分。其中维生素C的含量在果品中名列前茅，有维生素王之美称。
7双歧杆菌双歧杆菌Bifidobacterium是1899年由法国学者Tissier从母乳营养儿的粪便中分离出的一种厌氧的革兰氏阳性杆菌，末端常常分叉，故名双歧杆菌。双歧杆菌属革兰氏阳性、厌氧、不运动、无芽孢、形态多变的杆菌,其染色不规则,过氧化氢酶呈阴性。菌落光滑,凸圆边缘完整,乳脂呈白色,闪光并有柔软质地。葡萄糖代谢属异型发酵,具有磷酸转酮酶活性,可将2mol葡萄糖酵解为3mol乙酸和2mol乳酸。广泛存在于人和动物的肠道,反刍动物的瘤胃,以及人的齿缝中。其最适生存温度为37～42℃,最适pH值6.5～7.0。
双歧杆菌具有以下治疗效果：（1）维护肠道正常细菌菌群平衡，抑制病原菌的生长，防止便秘，下痢和胃肠障碍等；（2）抗肿瘤；（3）在肠道内合成维生素、氨基酸和提高机体对钙离子的吸收；（4）降低血液中胆固醇水平，防治高血压；（5）改善乳制品的耐乳糖性，提高消化率；（6）增强人体免疫机能，预防抗生素的副作用，抗衰老，延年益寿。
一参五果配合使用制备的高丽红参罗汉果汤具有强身健体的功能。
发明内容
1、一种高丽红参罗汉果汤的制备方法，特征在于其步骤如下：
（1）原辅料组成及重量配比为高丽红参5年根粉末1.5-3g、罗汉果1.5-3g、桑椹1-2g、山楂1-2g、乌梅1-2g、大枣1-2g、乙基麦芽酚0.001-0.002g、0.1-0.2%双歧杆菌粉末；
（2）将（1）中高丽红参5年根粉末、罗汉果、桑椹、山楂、乌梅、大枣放入不锈钢容器内，加水煎煮，加水量为高丽红参5年根粉末、罗汉果、桑椹、山楂、乌梅、大枣总重量的5-6倍，温度80-95℃，时间3-4h，过滤，得滤液和残渣；
（3）将（2）中残渣再加水煎煮，加水量为高丽红参5年根粉末、罗汉果、桑椹、山楂、乌梅、大枣总重量的4-5倍，温度80-95℃，时间2-3h，过滤，得滤液和残渣；
（4）将（3）中残渣再加水煎煮，加水量为高丽红参5年根粉末、罗汉果、桑椹、山楂、乌梅、大枣总重量的3-4倍，温度80-95℃，时间1-2h，过滤，得滤液和残渣；
（5）将（2）、（3）和（4）中残渣压滤，并与（2）、（3）和（4）中滤液合并，加入0.1-0.2%双歧杆菌粉末，在温度37-42℃进行24～48h发酵；
（6）将（5）中滤液减压浓缩至20-40mL，加入乙基麦芽酚0.001-0.002g，装罐、装瓶或装袋即可。
具体实施方式
本发明所述的涉及一种高丽红参罗汉果汤的制备方法包括以下实施例，下面的实施例可进一步说明本发明，但不以任何方式限制本发明。
实施例1:
1、一种高丽红参罗汉果汤的制备方法，特征在于其步骤如下：
（1）原辅料组成及重量配比为高丽红参5年根粉末1.5g、罗汉果1.5g、桑椹1g、山楂1g、乌梅1g、大枣1g、乙基麦芽酚0.001g、0.1%双歧杆菌粉末；
（2）将（1）中高丽红参5年根粉末、罗汉果、桑椹、山楂、乌梅、大枣放入不锈钢容器内，加水煎煮，加水量为高丽红参5年根粉末、罗汉果、桑椹、山楂、乌梅、大枣总重量的5倍，温度80℃，时间3h，过滤，得滤液和残渣；
（3）将（2）中残渣再加水煎煮，加水量为高丽红参5年根粉末、罗汉果、桑椹、山楂、乌梅、大枣总重量的4倍，温度80℃，时间2h，过滤，得滤液和残渣；
（4）将（3）中残渣再加水煎煮，加水量为高丽红参5年根粉末、罗汉果、桑椹、山楂、乌梅、大枣总重量的3倍，温度80℃，时间1h，过滤，得滤液和残渣；
（5）将（2）、（3）和（4）中残渣压滤，并与（2）、（3）和（4）中滤液合并，加入0.1%双歧杆菌粉末，在温度37℃进行48h发酵；
（6）将（5）中滤液减压浓缩至20mL，加入乙基麦芽酚0.001g，装罐、装瓶或装袋即可。
实施例2:
1、一种高丽红参罗汉果汤的制备方法，特征在于其步骤如下：
（1）原辅料组成及重量配比为高丽红参5年根粉末3g、罗汉果3g、桑椹2g、山楂2g、乌梅2g、大枣2g、乙基麦芽酚0.002g、0.2%双歧杆菌粉末；
（2）将（1）中高丽红参5年根粉末、罗汉果、桑椹、山楂、乌梅、大枣放入不锈钢容器内，加水煎煮，加水量为高丽红参5年根粉末、罗汉果、桑椹、山楂、乌梅、大枣总重量的6倍，温度95℃，时间4h，过滤，得滤液和残渣；
（3）将（2）中残渣再加水煎煮，加水量为高丽红参5年根粉末、罗汉果、桑椹、山楂、乌梅、大枣总重量的5倍，温度95℃，时间3h，过滤，得滤液和残渣；
（4）将（3）中残渣再加水煎煮，加水量为高丽红参5年根粉末、罗汉果、桑椹、山楂、乌梅、大枣总重量的4倍，温度95℃，时间2h，过滤，得滤液和残渣；
（5）将（2）、（3）和（4）中残渣压滤，并与（2）、（3）和（4）中滤液合并，加入0.2%双歧杆菌粉末，在温度42℃进行24h发酵；
（6）将（5）中滤液减压浓缩至40mL，加入乙基麦芽酚0.002g，装罐、装瓶或装袋即可。
Claims (1)
1.一种高丽红参罗汉果汤的制备方法，特征在于其步骤如下：
（1）原辅料组成及重量配比为高丽红参5年根粉末1.5-3g、罗汉果1.5-3g、桑椹1-2g、山楂1-2g、乌梅1-2g、大枣1-2g、乙基麦芽酚0.001-0.002g、0.1-0.2%双歧杆菌粉末；
（2）将（1）中高丽红参5年根粉末、罗汉果、桑椹、山楂、乌梅、大枣放入不锈钢容器内，加水煎煮，加水量为高丽红参5年根粉末、罗汉果、桑椹、山楂、乌梅、大枣总重量的5-6倍，温度80-95℃，时间3-4h，过滤，得滤液和残渣；
（3）将（2）中残渣再加水煎煮，加水量为高丽红参5年根粉末、罗汉果、桑椹、山楂、乌梅、大枣总重量的4-5倍，温度80-95℃，时间2-3h，过滤，得滤液和残渣；
（4）将（3）中残渣再加水煎煮，加水量为高丽红参5年根粉末、罗汉果、桑椹、山楂、乌梅、大枣总重量的3-4倍，温度80-95℃，时间1-2h，过滤，得滤液和残渣；
（5）将（2）、（3）和（4）中残渣压滤，并与（2）、（3）和（4）中滤液合并，加入0.1-0.2%双歧杆菌粉末，在温度37-42℃进行24～48h发酵；
（6）将（5）中滤液减压浓缩至20-40mL，加入乙基麦芽酚0.001-0.002g，装罐、装瓶或装袋即可。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410004204.2A CN103750425B (zh) | 2014-01-06 | 2014-01-06 | 一种高丽红参罗汉果汤的制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410004204.2A CN103750425B (zh) | 2014-01-06 | 2014-01-06 | 一种高丽红参罗汉果汤的制备方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103750425A CN103750425A (zh) | 2014-04-30 |
| CN103750425B true CN103750425B (zh) | 2015-02-04 |
Family
ID=50517878
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410004204.2A Active CN103750425B (zh) | 2014-01-06 | 2014-01-06 | 一种高丽红参罗汉果汤的制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103750425B (zh) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105360871A (zh) * | 2015-09-18 | 2016-03-02 | 洛阳古草生物科技有限公司 | 一种具有开胃健脾功效的固体饮料及其制备方法 |
| CN105942068A (zh) * | 2016-05-28 | 2016-09-21 | 环翠楼红参生物科技股份有限公司 | 一种高丽红参汤的制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1070916C (zh) * | 1995-12-15 | 2001-09-12 | 陈刚德 | 一种双补酒 |
| CN102265949A (zh) * | 2011-08-26 | 2011-12-07 | 吉林紫鑫药业股份有限公司 | 人参普洱茶及其生产工艺 |
| KR101381112B1 (ko) * | 2011-11-30 | 2014-04-14 | 한국식품연구원 | 홍삼을 이용한 홍경천 발효물의 제조방법 및 그 발효물을 포함하는 피로 회복 및 운동능력 향상용 조성물 |
| CN103484288B (zh) * | 2013-08-19 | 2014-12-24 | 刘军科 | 提高药酒药效的方法及益生菌组合物 |
-
2014
- 2014-01-06 CN CN201410004204.2A patent/CN103750425B/zh active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN103750425A (zh) | 2014-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103564300B (zh) | 一种高丽红参蜜片的加工工艺 | |
| CN103609992B (zh) | 一种高丽红参膏的制备方法 | |
| CN103725572B (zh) | 一种高丽红参酒的制备方法 | |
| CN103689743B (zh) | 一种高丽红参桑椹饮料的制备方法 | |
| CN103725467B (zh) | 一种高丽参红葡萄酒的制备方法 | |
| CN103749827B (zh) | 一种高丽红参无花果茶的制备方法 | |
| CN104109609A (zh) | 糯米酒荞麦果汁饮料及其制备方法 | |
| KR101520332B1 (ko) | 천연물 약재가 함유된 기능성 커피 및 이의 제조방법 | |
| CN105942068A (zh) | 一种高丽红参汤的制备方法 | |
| CN103695275B (zh) | 一种双参酒的制备方法 | |
| CN103750425B (zh) | 一种高丽红参罗汉果汤的制备方法 | |
| CN104798950A (zh) | 免疫功夫茶及其制备方法 | |
| CN103564572B (zh) | 一种高丽红参汤的制备方法 | |
| CN104187714B (zh) | 一种高丽红参膳食纤维膨化粉的制备方法 | |
| CN103704458B (zh) | 一种高丽参蜜片的加工工艺 | |
| CN103689602B (zh) | 一种高丽红参口服液的制备方法 | |
| CN103689742B (zh) | 一种高丽红参无花果饮料的制备方法 | |
| CN103719863B (zh) | 一种高丽红参咀嚼片的制备方法 | |
| CN103719499B (zh) | 一种高丽红参茶的制备方法 | |
| KR102462817B1 (ko) | 진안홍삼데일리 건강기능식품 조성물의 제조방법 | |
| CN103704840B (zh) | 一种高丽红参青果饮料的制备方法 | |
| CN107582735A (zh) | 一种调理痰湿体质的黑茶饮 | |
| CN106889273A (zh) | 一种具有降血脂作用的白芍复方茶 | |
| CN103689744B (zh) | 一种高丽红参龙眼饮料的制备工艺 | |
| CN103704459B (zh) | 一种高丽红参硬糖果的制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| PP01 | Preservation of patent right | ||
| PP01 | Preservation of patent right |
Effective date of registration: 20190905 Granted publication date: 20150204 |
|
| PD01 | Discharge of preservation of patent | ||
| PD01 | Discharge of preservation of patent |
Date of cancellation: 20210905 Granted publication date: 20150204 |
|
| CP03 | Change of name, title or address | ||
| CP03 | Change of name, title or address |
Address after: 264200 No. 58, Taibei Road, Lingang Economic and Technological Development Zone, Weihai City, Shandong Province Patentee after: Shenyuanzhuang Biotechnology Co.,Ltd. Address before: 264211 No. 58, Taipei Road, industrial new area, Weihai City, Shandong Province Patentee before: WEIHAI HUANCUILOU RED GINSENG TECHNOLOGY Co.,Ltd. |